Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Controlled activation of complement components for use as endogenous adjuvant

Controlled activation of complement components for use as endogenous adjuvant

US Patent 10238735 · Granted Mar 26, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Differential diagnosis of eczema and psoriasis2024
Non-human papillomaviruses for gene delivery in vitro and in vivo2024
Ratio of immune cells as prognostic indicator of therapeutic success in allergen2023
Induction of antigen-specific tolerance by peripheral phagocytosis2021
Induction of antigen-specific tolerance by peripheral phagocytosis2021
Induction of antigen-specific tolerance by peripheral phagocytosis2021
Cloning of honey bee allergen2016
Cloning and recombinant productions of Vespula venom protease and methods of use2014
RSV F-protein and its use2013
Complement depletion using recombinant human C-3 derivatives2012
Complement depletion using recombinant human C-3 derivatives2012
Chimera of human IgE receptor α-chain and avian constant immuno-globulin domains2011